bluebird bio, Inc. BLUE
Set alert
4.97 0.00 0.00%
At close · Jun 2
4.97 Day range 4.97
52-week range unavailable
- YTD
- -40.41%
- 1 year
- -72.25%
- Open
- 4.97
- Prev close
- 4.97
- Mkt cap
- 75.74M
- Vol
- 1.25M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.97
- High
- 4.97
- Forward P/E
- -11.98
- Beta
- 0.80
- Short ratio
- 9.53
- Inst. own
- 43.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.54
- 200-d avg
- 16.13
- 1y target
- 37.71
Analyst view
Consensus: hold
Hold
Price target (mean) 37.71 +658.8% upside
Now 4.97
- Target (low)
- 10.00
- Target (mean)
- 37.71
- Target (high)
- 80.00
Ratings (0m) 10 2 buy · 6 hold · 2 sell
- Strong buy1
- Buy1
- Hold6
- Sell0
- Strong sell2
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 11
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -5.75 | -7.40 – -4.40 | -15.60 | +63.2% | 26.08M | +232.9% | 4 |
| Next quarter | -3.21 | -5.60 – -1.60 | -7.20 | +55.5% | 37.72M | +103.1% | 3 |
| Current year | -27.19 | -29.20 – -24.55 | -55.50 | +51.0% | 72.13M | +144.6% | 4 |
| Next year | -11.08 | -23.60 – 0.30 | -27.19 | +59.3% | 247.27M | +242.8% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Nov 15, 2024 | B of A Securities | Downgrade | Buy | Neutral |
| Nov 15, 2024 | Barclays | Maintained | Overweight | Overweight |
| Sep 25, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 16, 2024 | Cantor Fitzgerald | Reiterated | — | Neutral |
| Aug 15, 2024 | B of A Securities | Maintained | Buy | Buy |
| Aug 15, 2024 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Aug 15, 2024 | Barclays | Maintained | Overweight | Overweight |
| Aug 15, 2024 | Baird | Maintained | Outperform | Outperform |
| Aug 15, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Mar 27, 2024 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Mar 27, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Mar 19, 2024 | Wedbush | Maintained | Neutral | Neutral |
| Mar 5, 2024 | HSBC | Maintained | Reduce | Reduce |
| Dec 21, 2023 | B of A Securities | Maintained | Buy | Buy |
| Dec 15, 2023 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 12, 2023 | Baird | Maintained | Outperform | Outperform |
| Dec 11, 2023 | B of A Securities | Maintained | Buy | Buy |
| Dec 8, 2023 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Nov 8, 2023 | Raymond James | Maintained | Outperform | Outperform |
| Oct 17, 2023 | Cantor Fitzgerald | Initiated | — | Neutral |
| Sep 6, 2023 | HSBC | Initiated | — | Buy |
| Jul 19, 2023 | B of A Securities | Upgrade | Neutral | Buy |
| Jul 11, 2023 | Morgan Stanley | Reiterated | Underweight | Underweight |
| Jun 1, 2023 | Barclays | Upgrade | Equal-Weight | Overweight |
| Apr 28, 2023 | JP Morgan | Initiated | — | Overweight |
| Apr 3, 2023 | Morgan Stanley | Maintained | — | Underweight |
| Mar 30, 2023 | RBC Capital | Reiterated | — | Sector Perform |
| Mar 30, 2023 | B of A Securities | Maintained | — | Neutral |
| Mar 7, 2023 | Baird | Initiated | — | Outperform |